Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
European Journal of Immunology|April 11, 2012
Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patientsDàlia Raϊch-Regué, Laia Grau-López, Mar Naranjo-Gómez, et al.
BMC Neurology|September 26, 2012
Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patientsLaia Grau-López, Maria Luisa Granada, Dàlia Raïch-Regué, et al.
CNS Neuroscience & Therapeutics|April 16, 2016
Baseline Differences in Minor Lymphocyte Subpopulations may Predict Response to Fingolimod in Relapsing-Remitting Multiple Sclerosis PatientsAina Teniente-Serra, José Vicente Hervás, Bibiana Quirant-Sánchez, et al.
CNS Neuroscience & Therapeutics|May 9, 2019
Optimal response to dimethyl fumarate is mediated by a reduction of Th1-like Th17 cells after 3 months of treatmentMaría José Mansilla, Juan Navarro-Barriuso, Silvia Presas-Rodríguez, et al.
Biomedicines|December 24, 2021
Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple SclerosisBibiana Quirant-Sánchez, María José Mansilla, Juan Navarro-Barriuso, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 6, 2015
Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapsesCristina Ramo-Tello, Mar Tintoré, Alex Rovira, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 18, 2023
Treatment of older patients with multiple sclerosis: Results of an International Delphi SurveyHayrettin Tumani, Patricia K Coyle, Claudia Cárcamo, et al.
Scientific Reports|October 10, 2018
Comparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycinJuan Navarro-Barriuso, María José Mansilla, Mar Naranjo-Gómez, et al.
CNS Neuroscience & Therapeutics|November 19, 2014
Beneficial effect of tolerogenic dendritic cells pulsed with MOG autoantigen in experimental autoimmune encephalomyelitisMaría José Mansilla, Carla Sellès-Moreno, Sara Fàbregas-Puig, et al.
Frontiers in Immunology|July 12, 2019
MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis PatientsJuan Navarro-Barriuso, María José Mansilla, Bibiana Quirant-Sánchez, et al.
Pageof 9